Skip Nav
Sophie Turner
Sophie Turner's Hair Is Key to the "Subliminal Messages" on Game of Thrones
Beauty News
3 Wild Facts About the Makeup and Special Effects on Game of Thrones
The Royals
Did You Ever Notice Princess Diana Was Obsessed With Blue Eyeliner?

Botox Competitor Xeomin Approved by FDA

Botox's Newest Competitor Could Be Much Cheaper

Botox is incredibly popular, but although Botox is a bargain in comparison to other injectables or traditional plastic surgery, it still carries a pretty hefty price tag — at least $10 a unit, with most people requiring between 20 and 40 units every four or six months to "erase" their wrinkles. This year, though, the FDA has approved another botulinum toxin, Xeomin. It's very similar to Botox, but one small factor could make it much cheaper.

Xeomin is a version of botulinum toxin that has already been available to doctors for years. It helps stop muscle spasms, so it's become a common treatment for people who have chronic neck or eyelid twitching. It's similar to Botox in effectiveness, lasting time, and safety. Where it differs however, is in storage and preparation. Xeomin could start a price war simply because it's powdered and doesn't need to be refrigerated. Botox and previously approved alternative Dysport are both liquids that must be refrigerated at all times, so shipping and storing them isn't easy. Xeomin, on the other hand, can sit on shelves for years and is simple to mix into saline for injection. And Xeomin's creator, Merz Pharmaceuticals, just lowered its price by 20 percent, making it even more competitive. It's a lot less effort and expense for providers, and the hope is that they'll pass the savings along to consumers.

Image Source: Thinkstock
Join The Conversation
Pretty Zombie Cosmetics Halloween Makeup
Beyonce Uses Elmers Glue on Eyebrows
Game of Thrones Night King Getting Makeup Done
Sailor Moon Makeup Brushes
From Our Partners
Latest Beauty
All the Latest From Ryan Reynolds